HIV Dementia with a Decreased Cardiac 123I-metaiodobenzylguanidine Uptake Masquerading as Dementia with Lewy Bodies

Intern Med. 2018 Oct 15;57(20):3007-3010. doi: 10.2169/internalmedicine.0876-18. Epub 2018 May 18.

Abstract

Cardiac 123I-metaiodobenzylguanidine (MIBG) scintigraphy is a promising biomarker for dementia with Lewy bodies (DLB). However, we experienced a patient with cognitive decline, parkinsonism, and a decreased MIBG uptake who turned out to have HIV dementia. Normal dopamine transporter single-photon emission computed tomography reduced the possibility of comorbid Lewy body pathology causing the patient' s parkinsonism. The decreased MIBG uptake was most likely due to postganglionic sympathetic nerve denervation, which can also be caused by HIV. This case further emphasizes the importance of excluding other causes of autonomic neuropathy, including HIV infection, before interpreting MIBG scans.

Keywords: HIV; HIV dementia; MIBG scintigraphy; dementia with Lewy bodies; parkinsonism.

Publication types

  • Case Reports

MeSH terms

  • 3-Iodobenzylguanidine / blood*
  • AIDS Dementia Complex / diagnosis
  • AIDS Dementia Complex / drug therapy*
  • AIDS Dementia Complex / etiology*
  • Anti-Retroviral Agents / therapeutic use*
  • Biomarkers / blood
  • Cognitive Dysfunction / diagnosis
  • Cognitive Dysfunction / drug therapy*
  • Fatal Outcome
  • HIV Infections / complications*
  • HIV Infections / mortality
  • Humans
  • Lewy Bodies
  • Lewy Body Disease / drug therapy
  • Lewy Body Disease / etiology*
  • Male
  • Middle Aged
  • Radiopharmaceuticals / blood
  • Sympathetic Nervous System / diagnostic imaging
  • Tomography, Emission-Computed, Single-Photon / methods

Substances

  • Anti-Retroviral Agents
  • Biomarkers
  • Radiopharmaceuticals
  • 3-Iodobenzylguanidine